Skip to main navigation menu Skip to main content Skip to site footer

EFFECTIVENESS OF HYDROTHERAPY IN REDUCING PAIN AND ENHANCING QUALITY OF LIFE IN PAEDIATRIC SICKLE CELL ANEMIA PATIENTS

Abstract

This quasi-experimental pretest–posttest study assessed the effectiveness of hydrotherapy in reducing pain and improving quality of life among 80 pediatric patients with sickle cell disease at Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria, of whom 40 received a structured hydrotherapy protocol. Pain intensity (back, bone, stomach and general pain) and multidimensional quality-of-life indicators were measured before and after the intervention using a validated questionnaire and analyzed with descriptive statistics and paired inferential tests at a 0.05 significance level. Mean scores showed reductions in specific pain domains, including back pain (1.90 prehydrotherapy vs 1.38 posthydrotherapy) and worst stomach-ache (2.38 vs 2.18), while caregivers and patients reported beneficial impacts such as prevention of dehydration (mean 3.24), reduced chances of sickling (mean 3.14) and improved general clinical condition (mean 3.14), even though several pain ratings remained within the discomforting range. These findings indicate that hydrotherapy is a useful adjunct to standard care for mitigating selected pain dimensions and enhancing aspects of clinical and functional well-being in children with sickle cell disease in a low-resource setting.

Keywords

Hydrotherapy; Sickle cell disease; Pediatric pain; Quality of life; Quasi- experimental design; Nigeria.

PDF